Now what?

Each year, about 1 million people are told they have some form of cancer. Like others with cancer, you have questions to ask and decisions to make. You have been diagnosed with a serious illness. But your life continues to have meaning and purpose. It may help to know that many people with cancer survive, live many years of good quality life, and continue to (or learn to) live their lives to the fullest.



But most people have very similar questions when they are first diagnosed.



1. Do I tell others I have cancer? Who do I tell and how?

2. Do I want to share my feelings?



3. How do I choose a doctor? Do I need a second opinion?

What if I want to change doctors?



4. How do I learn about treatment and health care coverage?



5. What will this mean for my friends and family?



6. How can my family and friends help?



7. How can The Leukemia & Lymphoma Society help?



They have free resources and can help you decide answers to all of those questions. For more information, call the Information Resource Center at (800) 955-4572 or go to http://www.leukemia-lymphoma.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap